Views

CrossRef citations to date

Altmetric

Oncology

Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data

Chakkarin BurudpakdeeIMS Health, Fairfax, VA, USA; ;University of North Carolina at Charlotte, Charlotte, NC, USA; Correspondence[email protected]

Huamao Mark LinMillennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;

Weiying WangNucleusX Market Access, Warren, NJ, USA;

Arpamas SeetasithIMS Health, Fairfax, VA, USA;

Yanyan ZhuMillennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;

Vijayveer BonthapallyMillennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited;

Kenneth R. CarsonWashington University School of Medicine, St. Louis, MO, USA

show all

Figures & data

Figure 1. Selection of PTCL patients. PTCL, peripheral T-cell lymphoma.

Table 1. Patient demographics and baseline characteristics.

Download CSV Display Table

Table 2. Healthcare resource utilization rates and costs.

Download CSV Display Table

Figure 2. Breakdown of “other” patient services based on cost distribution.

Table 3. Most common diagnosis codes associated with hospitalizations.

Download CSV Display Table

Table 4. Patient-level breakdown of the top 20 most common procedures associated with hospitalization.

Download CSV Display Table

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data

Table 1. Patient demographics and baseline characteristics.

Table 2. Healthcare resource utilization rates and costs.

Table 3. Most common diagnosis codes associated with hospitalizations.

Table 4. Patient-level breakdown of the top 20 most common procedures associated with hospitalization.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data

Figures & data

Table 1. Patient demographics and baseline characteristics.

Table 2. Healthcare resource utilization rates and costs.

Table 3. Most common diagnosis codes associated with hospitalizations.

Table 4. Patient-level breakdown of the top 20 most common procedures associated with hospitalization.

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date